Background: The aim of this study was to ascertain if participants diagnosed with any mild cognitive disorder (MCD) visited a general practitioner (GP) more than those without MCD and the effect of either depression or arthritis on GP use longitudinally. Methods: 2,551 participants aged 60-64 years at baseline completed the Personality and Total Health Through Life (PATH) study in Canberra. Follow-up data were collected after 4 and 8 years. A cognitive screening battery was used to screen participants into a substudy of MCD. Results: Participants with any MCD had greater GP use than cognitively healthy participants across all three waves (wave 1, M = 7.35 vs. 5.59; wave 2, M = 7.77 vs. 5.86; wave 3, M = 9.01 vs. 6.81). After adjusting for demographic and health factors, MCD was a significant predictor of GP use at all three waves (p < 0.05, CI 0.84-0.99). Conclusion: This study has shown that MCD is associated with a higher use of GP visits, especially if the patient has a comorbid condition.

1.
Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, Burke JR, Hurd MD, Potter GG, Rodgers WL, et al: Prevalence of cognitive impairment without dementia in the United States. Ann Intern Med 2008;148:427-434.
2.
Chertkow H, Massoud F, Nasreddine Z, Belleville S, Joanette Y, Bocti C, Drolet V, Kirk J, Freedman M, Bergman H: Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia. CMAJ 2008;178:1273-1285.
3.
Alexopoulos P, Grimmer T, Perneczky R, Domes G, Kurz A: Progression to dementia in clinical subtypes of mild cognitive impairment. Dement Geriatr Cogn Disord 2006;22:27-34.
5.
Comijs HC, Dik MG, Aartsen MJ, Deeg DJH, Jonker C: The impact of change in cognitive functioning and cognitive decline on disability, well-being, and the use of healthcare services in older persons. Dement Geriatr Cogn Disord 2005;19:316-323.
6.
Hesseberg K, Bentzen H, Ranhoff AH, Engedal K, Bergland A: Disability in instrumental activities of daily living in elderly patients with mild cognitive impairment and Alzheimer's disease. Dement Geriatr Cogn Disord 2013;36:146.
7.
Fowler NR, Morrow LA, Tu L-C, Landsittel DP, Snitz BE, Rodriquez EG, Saxton JA: Association between cognitive decline in older adults and use of primary care physician services in Pennsylvania. J Prim Care Community Health 2012;3:201-209.
8.
Luck T, Abholz H-H, Moesch E, Gorfer S, Angermeyer MC, Maier W, Weyerer S, Riedel-Heller SG, Kaduszkiewicz H, Bickel H, et al: Mild cognitive impairment in general practice: age-specific prevalence and correlate results from the German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe). Dement Geriatr Cogn Disord 2007;24:307-316.
9.
Ramakers I, Visser PJ, Aalten P, Boesten JHM, Metsemakers JFM, Jolles J, Verhey FRJ: Symptoms of preclinical dementia in general practice up to five years before dementia diagnosis. Dement Geriatr Cogn Disord 2007;24:300-306.
10.
Callahan CM, Hendrie HC, Tierney WM: Documentation and evaluation of cognitive impairment in elderly primary care patients. Ann Intern Med 1995;122:422.
11.
Apostolova LG, Cummings JL: Neuropsychiatric manifestations in mild cognitive impairment: a systematic review of the literature. Dement Geriatr Cogn Disord 2008;25:115-126.
12.
Geldmacher DS, Kirson NY, Birnbaum HG, Eapen S, Kantor E, Kate CA, Joish VN: Pre-diagnosis excess acute care costs in Alzheimer's patients among a US Medicaid population. Appl Health Econ Health Policy 2013;11:407-413.
13.
Jennifer AY, Linda C, Robert TW: Mild cognitive impairment and mood: a systematic review. Rev Clin Gerontol 2013;23:317.
14.
AIHW: Australia's Health 2014. Canberra, AIHW, 2014.
15.
Joyce CM, Wimalaratne S, McNeil JJ: Future demand for general practice services: effects of population changes and trends in service use. Aust Health Rev 2003;26:26-33.
16.
Parslow R, Jorm A, Christensen H, Jacomb P, Rodgers B: Gender differences in factors affecting use of health services: an analysis of a community study of middle-aged and older Australians. Soc Sci Med 2004;59:2121-2129.
17.
Walsh EG, Wu B, Mitchell JB, Berkmann LF: Cognitive function and acute care utilization. J Gerontol B Psychol Sci Soc Sci 2003;58:S38-S49.
18.
Toseland RW, McCallion P, Gerber T, Banks S: Predictors of health and human services use by persons with dementia and their family caregivers. Soc Sci Med 2002;55:1255-1266.
19.
Roelands M, Van Oyen H, Depoorter A, Baro F, Van Oost P: Are cognitive impairment and depressive mood associated with increased service utilisation in community-dwelling elderly people? Health Soc Care Community 2003;11:1-9.
20.
Albert SM, Glied S, Andrews H, Stern Y, Mayeux R: Primary care expenditures before the onset of Alzheimer's disease. Neurology 2002;59:573-578.
21.
Zimmer Z, Ofstedal MB, Chang M-C: Impact of cognitive status and decline on service and support utilization among older adults in Taiwan. Res Aging 2001;23:267-303.
22.
Glynn LG, Valderas JM, Healy P, Burke E, Newell J, Gillespie P, Murphy AW: The prevalence of multimorbidity in primary care and its effect on health care utilization and cost. Fam Pract 2011;28:516-523.
23.
Salisbury C, Johnson L, Purdy S, Valderas JM, Montgomery AA: Epidemiology and impact of multimorbidity in primary care: a retrospective cohort study. Br J GenPract 2011;61:e12-e21.
24.
Britt H, Miller GC, Henderson J, Bayram C, Harrison C, Valenti L, Wong C, Gordon J, Pollack AJ, Pan Y, et al: General Practice Activity in Australia 2013-14. General Practice Series No. 36. Sydney, Sydney University Press, 2014.
25.
Shin SY, Katz P, Wallhagen M, Julian L: Cognitive impairment in persons with rheumatoid arthritis. Arthritis Care Res 2012;64:1144-1150.
26.
Steenland K, Karnes C, Seals R, Carnevale C, Hermida A, Levey A: Late-life depression as a risk factor for mild cognitive impairment or Alzheimer's disease in 30 US Alzheimer's disease centers. J Alzheimers Dis 2012;31:265.
27.
Anstey KJ, Christensen H, Butterworth P, Easteal S, Mackinnon A, Jacomb T, Maxwell K, Rodgers B, Windsor T, Cherbuin N, et al: Cohort profile: the PATH through life project. Int J Epidemiol 2012;41:951.
28.
Cherbuin N, Reglade-Meslin C, Kumar R, Jacomb P, Easteal S, Christensen H, Sachdev P, Anstey KJ: Risk factors of transition from normal cognition to mild cognitive disorder: the PATH through Life Study. Dement Geriatr Cogn Disord 2009;28:47-55.
29.
Parslow R, Jorm AF, Christensen H, Broom DH, Strazdins L, D'Souza RM: The impact of employee level and work stress on mental health and GP service use: an analysis of a sample of Australian government employees. BMC Public Health 2004;4:1-9.
30.
Anstey KJ, Cherbuin N, Eramudugolla R, Sargent-Cox K, Easteal S, Kumar R, Sachdev P: Characterizing mild cognitive disorders in the young-old over 8 years: prevalence, estimated incidence, stability of diagnosis, and impact on IADLs. Alzheimers Dement 2013;9:640-648.
31.
Folstein MF, Robins LN, Helzer JE: The Mini-mental state examination. Arch Gen Psychiatry 1983;40:812.
32.
Delis D, Kramer J, Kaplan E, Ober B: California Verbal Learning Test. San Antonio, Psychological Corporation Harcourt Brace Jovanovich, 1987.
33.
Smith A: Symbol Digit Modalities Test (SDMT) Manual. Los Angeles, Western Psychological Services, 1982.
34.
Tiffin J: Purdue Pegboard: Examiners Manual. Rosemont, London House, 1968.
35.
Anstey K, Dear K, Christensen H, Jorm A: Biomarkers, health, lifestyle and demographic variables as correlates of reaction time performance in early, middle and late adulthood. Q J Exp Psychol A 2005;58A:5-21.
36.
Kumar R, Dear KBG, Christensen H, Ilschner S, Jorm AF, Meslin C, Rosenman SJ, Sachdev PS: Prevalence of mild cognitive impairment in 60- to 64-year-old community-dwelling individuals: The Personality and Total Health through Life 60+ Study. Dement Geriatr Cogn Disord 2005;19:67-74.
37.
Anstey KJ, Cherbuin N, Christensen H, Burns R, Reglade-Meslin C, Salim A, Kumar R, Jorm AF, Sachdev P: Follow-up of mild cognitive impairment and related disorders over four years in adults in their sixties: The PATH Through Life Study. Dement Geriatr Cogn Disord 2008;26:226-233.
38.
Spitzer RL, Williams JB, Kroenke K, Hornyak R, McMurray J: Validity and utility of the PRIME-MD patient health questionnaire in assessment of 3,000 obstetric-gynecologic patients: the PRIME-MD Patient Health Questionnaire Obstetrics-Gynecology Study. Am J Obstet Gynecol 2000;183:759-769.
39.
Lubben J, Blozik E, Gillmann G, Iliffe S, von Renteln Kruse W, Beck JC, Stuck AE: Performance of an abbreviated version of the Lubben Social Network Scale Among three European community-dwelling older adult populations. Gerontologist 2006;46:503-513.
40.
Luber MP, Meyers BS, Williams-Russo PG, Hollenberg JP, DiDomenico TN, Charlson ME, Alexopoulos GS: Depression and service utilization in elderly primary care patients. Am J Geriatr Psychiatry 2001;9:169-176.
41.
Põlluste K, Kallikorm R, Meiesaar K, Lember M: Use of general practice and rheumatology outpatient services in rheumatoid arthritis. Fam Pract 2012;29:433-440.
42.
Hoenig JM, Heisey DM: The abuse of power: the pervasive fallacy of power calculations for data analysis. Am Stat 2001;55:19-24.
43.
Nakagawa S, Foster TM: The case against retrospective statistical power analyses with an introduction to power analysis. Acta Ethologica 2004;7:103-108.
44.
Fowler NR: Accurate assessments of healthcare use along the course of cognitive decline. J Am Geriatr Soc 2013;61:450-451.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.